ZNTL
Zentalis Pharmaceuticals Llc
2.50$
-3.3%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| – | +115.2% | +314.3% | +29.1% | +17.3% | +1.5% | -23.4% | -32.9% | |
| – | +158.2% | +400.9% | +1.6% | +28.8% | +9.9% | -22.3% | -34.4% | |
| – | +167.3% | -18.3% | +9.1% | -28.2% | -34.9% | +20.9% | +6.2% | |
| – | +167.3% | +403.4% | +0.5% | +28.6% | +10.4% | -23.2% | -33.7% | |
| – | -84.7% | +197.9% | +531.9% | +167.2% | – | – | -61.4% | |
| – | – | – | – | – | – | – | – | |
| – | +990.8% | +27.6% | +125.1% | -5.4% | – | – | – | |
| – | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | -100.0% | – | |
| – | +0.0% | +0.0% | – | – | – | – | – | |
| – | +127.9% | +62.4% | +234.2% | +11.1% | +4.4% | -25.3% | -21.9% | |
| – | +140.0% | +92.0% | +53.6% | +28.9% | +22.5% | -24.0% | -30.7% | |
| – | – | +15.5% | +61.1% | +48.8% | +21.3% | +17.1% | +26.1% | |
| – | +25.0% | +101.9% | +33.8% | -3.0% | +32.7% | -50.2% | -3.1% | |
| – | +148.7% | +400.9% | +17.9% | +19.2% | +0.8% | -22.9% | -35.9% | |
| – | – | – | – | – | – | – | – | |
| – | +98.7% | +14.4% | +4.0% | +23.8% | +23.7% | +8.7% | +1.1% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.